These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension. Investigator Study Group. Meyer BH, Pauly NC. J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S77-80. PubMed ID: 7527107 [Abstract] [Full Text] [Related]
5. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age]. Gosse P, Vaur L, Dutrey-Dupagne C, Genes N, Destrée D, Elkik F. Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662 [Abstract] [Full Text] [Related]
6. Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group. Steiner G, Pauly NC. J Cardiovasc Pharmacol; 1994 Nov; 23 Suppl 4():S81-5. PubMed ID: 7527108 [Abstract] [Full Text] [Related]
7. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil]. Widimský J, Dzúrik R. Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054 [Abstract] [Full Text] [Related]
8. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL. Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [Abstract] [Full Text] [Related]
9. Efficacy and tolerance of trandolapril (0.5-2 mg) administered for 4 weeks in patients with mild-to-moderate hypertension. Investigator Study Group. De Bruijn JH, Orofiamma BA, Pauly NC. J Cardiovasc Pharmacol; 1994 Sep; 23 Suppl 4():S60-4. PubMed ID: 7527104 [Abstract] [Full Text] [Related]
10. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial. Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R. Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004 [Abstract] [Full Text] [Related]
11. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy. Breithaupt-Grögler K, Gerhardt G, Lehmann G, Notter T, Belz GG. Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695 [Abstract] [Full Text] [Related]
12. Once-daily monotherapy with trandolapril in the treatment of hypertension. Smith DH, Neutel JM, Black HR, Schoenberger JA, Weber MA. J Hum Hypertens; 1996 Feb; 10(2):129-34. PubMed ID: 8867568 [Abstract] [Full Text] [Related]
13. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group. J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224 [Abstract] [Full Text] [Related]
14. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR. Messerli F, Frishman WH, Elliott WJ, Bacher PH, Pepine CJ. Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313 [Abstract] [Full Text] [Related]
15. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M. Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [Abstract] [Full Text] [Related]
16. Influence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study. Gustafsson F, Køber L, Torp-Pedersen C, Per Hildebrandt. J Hypertens Suppl; 1998 Jan; 16(1):S65-70. PubMed ID: 9534100 [Abstract] [Full Text] [Related]
17. Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population. Shankar PK, Vidyasagar S, Adiga S, Naidu MU, Usha Rani P, Rao D, Bairy KL, Nair S, Jayaprakash B, Shashikiran U, Mukhyapranaprabhu. Indian J Physiol Pharmacol; 2006 Jan; 50(4):421-6. PubMed ID: 17402274 [Abstract] [Full Text] [Related]
18. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M. Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [Abstract] [Full Text] [Related]
19. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R. Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280 [Abstract] [Full Text] [Related]
20. Treatment of hypertension in the very old. Otterstad JE, Ruilope LM. Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289 [Abstract] [Full Text] [Related] Page: [Next] [New Search]